Examines the effects of retatrutide weekly injection on cardiovascular outcomes in obese (>27 BMI) patients who have cardiovascular disease.

Examines the effects of small interfering RNA molecule that reduces LPa on Cardiovascular outcomes in patients with raised Lpa and cardiovascular disease.

Examines the effects of ziltivikimab monthly injection on microvascular inflammation and outcomes in Heart failure in heart failure patients with active inflammation.

Cardiovascular outcome study comparing the cagrilintide combination with Semaglutide (Ozempic) versus placebo in patients with obesity and established cardiovascular disease.